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Already	  for	  many	  years	  we	  have	  been	  confronted	  with	  a	  worldwide	  increasing	  ten-­‐
dency	  of	  children	  who	  become	  obese.	  At	  the	  same	  time,	  there	  is	  also	  evidence	  that	  
obesity	   in	  childhood	   is	  on	   the	  basis	  of	   the	  metabolic	   syndrome	   in	  adulthood	  with	  
the	  well-­‐known	  pathology	  of	  hypertension,	  cardiovascular	  disease,	  diabetes	  melli-­‐
tus	  and	  stroke.	   In	   this	  study	  we	  tried	   to	  gain	  better	   insight	   in	   the	  development	  of	  
obesity,	   the	   possibilities	   of	   prevention	   and	  what	   obesity	  means	   in	   terms	   of	   body	  
composition.	  
	  
The	   first	   question	   to	   study	   concerned	   the	   epidemiology	   of	   obesity.	   Although	   it	   is	  
well-­‐known	  that	   the	  origin	  of	  obesity	   in	  adulthood	  often	  has	   to	  be	   found	   in	  child-­‐
hood,	  we	  did	  not	   find	   any	   increase	   in	  weight	   of	   the	  neonate	   born	  during	   the	   last	  
decades.	   In	   other	  words,	   there	   is	   no	   increase	   in	   prenatal	   growth	   despite	   a	  mean	  
increase	  in	  weight	  and	  length	  of	  the	  mothers	  known	  as	  the	  secular	  trend.	  In	  expla-­‐
nation	  may	  it	  be	  stated	  that	  it	  is	  assumed	  that	  the	  intrauterine	  environment	  and	  the	  
placental	  nutrition	   supply	  prevent	   the	   fetus	   from	  becoming	  overgrown	   to	  protect	  
the	  mother	  herself.	  The	  placenta	   is	  not	  simply	  a	  passive	  conduit	   for	  nutrients	  but	  
also	   responds	   to	  both	  maternal	   and	   fetal	   signals,	   altering	  placental	   transport	   and	  
metabolic	  function1,2.	  On	  the	  other	  hand,	  it	  is	  described	  that	  maternal	  weight	  gain	  in	  
early	  pregnancy	  has	  an	  influence	  on	  fetal	  weight	  probably	  mediated	  through	  raised	  
placental	  mass3,4.	  Nevertheless,	  the	  general	  idea	  is	  that	  if	  a	  child	  has	  the	  tendency	  to	  
achieve	   a	   weight	   and	   height	   outside	   the	   physiological	   borders,	   there	   might	   be	   a	  
mechanism	   to	   restrict	   the	   further	   intrauterine	   growth	   as	   is	   shown	   in	   our	   data	   of	  
birth	  weight	  and	  length	  gathered	  during	  the	  last	  years.	  
	  
The	  main	   concerns	   of	   obesity	   are	   the	   comorbidities	   like	   the	  metabolic	   syndrome	  
and	  numerous	  psychosocial	  problems,	  which	  transfer	  obesity	  into	  a	  serious	  disease.	  
Because	  the	  roots	  of	  obesity	  can	  often	  be	  found	  in	  childhood,	  it	  is	  significant	  to	  dis-­‐
cern	   those	   children	  who	  are	  becoming	  obese	   just	   based	  on	   abnormal	   food	   intake	  
often	  combined	  with	  a	   less	  degree	  of	  physical	  exertion	  and	  those	  who	  suffer	   from	  
insulin	  resistance	  from	  birth	  onwards.	  The	  last	  group	  is	  especially	  recognized	  in	  the	  
infants	   born	   after	   intra	   uterine	   growth	   retardation,	   the	   small	   for	   gestational	   age	  
(SGA)	  children.	  Thanks	  to	  the	  longitudinal	  growth	  study	  during	  the	  first	  four	  years	  
of	  age	  of	  a	  healthy	  Dutch	  population5,	  we	  were	  able	  to	  analyze	  the	  postnatal	  growth	  
of	  individual	  children	  during	  this	  period.	  	  
	  
We	  realize	  that	   the	  reference	  population	  was	  taken	  ten	  years	  ago	  but	  at	   the	  same	  
time	   these	   reference	   data	   compared	   to	   the	   last	   Dutch	   nationwide	   growth	   study	  
show	  that	  the	  so-­‐called	  secular	  trend	  has	  come	  to	  a	  stop	  for	  height.	  However,	  it	  did	  
not	   come	   to	   a	   stop	   for	  weight.	   This	   tendency	  of	   becoming	   taller	   and	  heavier	  was	  
originally	   an	   important	   indication	   of	   a	   population	  whose	   health	   gained	   thanks	   to	  
better	  feeding	  and	  less	  disease.	  While	  the	  mean	  increase	  in	  height	  stopped	  already	  
since	   more	   than	   ten	   years,	   weight	   gain	   is	   still	   going	   on	   for	   the	   population	   as	   a	  
whole.	  For	  that	  reason	  a	  comparison	  with	  an	  older	  reference	  population	  it	  is	  signifi-­‐
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cant	  to	  be	  informed	  about	  the	  start	  of	  the	  discrepancy	  between	  height	  and	  weight	  of	  
the	   Dutch	   population.	   Taking	   into	   account	   the	   information	   that	   height	   does	   not	  
increase	  anymore,	   the	   increase	   in	  Body	  Mass	   Index	   (BMI),	  which	  was	   seen	   in	   the	  
postnatal	  data,	  means	  a	  higher	  increase	  in	  weight.	  	  
Methods	  of	  analyzing	  growth	  of	  children	  
There	  are	  several	  methods	  to	  analyze	  the	  growth	  of	  a	  child	  and	  to	  determine	  over-­‐
weight	  or	  obesity.	  One	  can	  compare	  particular	  children	  of	  the	  same	  age,	  gender	  and	  
population	   to	   judge	   if	   its	   weight	   and	   height	   are	  within	   the	   normal	   range	   for	   the	  
population.	  Usually	  weight	   and	  height	   are	   expressed	   as	   a	   function	   of	   age.	  Weight	  
can	  also	  be	  expressed	  in	  relation	  to	  height	  as	  the	  BMI	  defined	  as	  weight	  (kg)	  divid-­‐
ed	  by	  squared	  height	  (m2).	  However,	  the	  above-­‐mentioned	  tendency	  of	  the	  popula-­‐
tion	   to	  become	  heavier	  with	  steady	  size	   led	   to	  an	   increase	   in	   the	  BMI	  as	   followed	  
from	  the	  formula.	  In	  case	  of	  an	  equal	  weight	  to	  height	  ratio	  a	  child	  (below	  the	  age	  of	  
10	  years)	  with	  a	  taller	  height	  has	  a	  higher	  BMI	  in	  contrast	  to	  a	  child	  (below	  the	  age	  
of	  10	  years)	  with	  a	  smaller	  height,	  taking	  the	  P3,	  P50	  and	  P97	  values	  into	  account.	  
Therefore	   the	   expression	   of	   weight	   versus	   height	   is	   more	   reliable	   in	   children.	   A	  
limitation	   of	   the	   anthropometric	   approach	   of	   weight	   is	   that	   the	   BMI	   as	   well	   as	  
weight	  for	  height	  does	  not	  distinct	  between	  fat	  mass	  (FM)	  and	  fat-­‐free	  mass	  (FFM)6.	  
In	  adipose	  children	  it	  is	  reasonable	  to	  ascribe	  the	  weight	  gain	  to	  an	  increase	  in	  FM.	  
At	  the	  same	  time	  in	  relatively	  lean	  children	  a	  lower	  weight	  is	  largely	  due	  to	  a	  shift	  
from	  FM	  to	  FFM.	  Because	  a	  large	  part	  of	  the	  FM	  is	  situated	  in	  the	  abdominal	  region,	  
Fredriks	  stated	  that	  waist	  circumference	  can	  be	  used	  as	  a	  better	  tool	  to	  screen	  for	  
increased	  abdominal	  fat	  in	  children7.	  
	  
To	  measure	   total	  body	   fat	  one	  needs	   the	  use	  of	  other	  methods.	  A	   rather	   complex	  
method	   is	   the	  underwater	  weighing.	  The	  difference	  of	  weight	   in	   the	  open	  air	  and	  
under	  water	  gives	  a	  good	  indication	  of	  the	  FM.	  An	  easy	  and	  reliable	  method	  is	  the	  
measurement	  of	  the	  FFM	  by	  means	  of	  Deuterium.	  Deuterium	  is	  a	  stable	  isotope	  of	  
hydrogen	  of	  which	  the	  natural	  presence	  in	  the	  body	  fluids	  is	  knowable	  by	  measur-­‐
ing	  Deuterium	  in	  the	  urine.	  After	  a	  known	  gift	  of	  Deuterium	  the	  new	  concentration	  
in	  the	  urine	  after	  equilibration	  of	  the	  Deuterium	  in	  all	  body	  segments,	  is	  equivalent	  
with	   the	   total	   body	   FFM.	  Distracting	   the	   result	   from	   total	   body	  weight	   delivers	   a	  
good	  estimate	  of	  total	  body	  fat.	  Minimal	  changes	  in	  body	  composition	  can	  be	  found	  
by	  using	  the	  Deuterium	  method.	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Small	  for	  gestational	  age	  children	  
Besides	  the	  evidence	  of	  the	  origin	  of	  the	  metabolic	  syndrome	  in	  SGA	  children,	  it	  is	  
also	  remarkable	  that	  their	  growth	  in	  length	  and	  height	  often	  stay	  behind	  the	  norm.	  
One	   of	   the	   factors	  mentioned	  with	   respect	   to	   the	   stunted	   growth	   SGA	   children	   is	  
reduced	   sensitivity	   for	   the	   insulin-­‐like	   growth	   factor	   1	   (IGF-­‐1)8.	   IGF-­‐1	   is	   mainly	  
secreted	  by	   the	   liver	  as	  a	   result	  of	   stimulation	  by	  growth	  hormone.	   IGF-­‐1	  expres-­‐
sion	   is	   required	   for	   achieving	  maximal	   growth.	   Short	   SGA	   children	   show	   plasma	  
IGF-­‐1	  levels	  that	  are	  in	  the	  lower	  normal	  range9.	  	  For	  that	  reason	  these	  children	  are	  
treated	   with	   recombinant	   human	   growth	   hormone	   (rhGH)	   nowadays.	   In	   general	  
they	   respond	   very	   good	   on	   this	   treatment	   and	   correct	   their	   height	   towards	   their	  
genetically	  defined	  percentile.	  At	  the	  same	  time	  it	  is	  known	  from	  that	  treatment	  of	  
growth	  hormone	  deficient	  (GHD)	  children	  with	  rhGH	  results	  in	  a	  change	  of	  the	  me-­‐
tabolism10.	  This	  change	  is	  assumed	  to	  be	  an	  effect	  of	  IGF-­‐I	  what	  is	  a	  primary	  regula-­‐
tor	  of	  systemic	  anabolism	  and	  muscle	  growth11.	  Growth	  hormone	  deficiency	  is	  as-­‐
sociated	   with	   increased	   body	   fat	   and	   a	   lower	   lean	   body	  mass.	   These	   changes	   in	  
body	   composition	   are	   associated	   with	   metabolic	   derangements	   including	   insulin	  
resistance.	  They	  normalize	  with	  growth	  hormone	  replacement	  therapy12.	  
	  
In	   this	   thesis	  we	   showed	   that	   treatment	  with	   rhGH	  has	   also	   a	   positive	  metabolic	  
effect	  on	  body	  composition	  of	  SGA	  children.	  The	  treatment	  with	  rhGH	  causes	  a	  shift	  
in	  body	  composition	  of	  FM	  towards	  FFM.	  After	  treatment	  with	  rhGH,	  SGA	  children	  
show	  an	   increase	   in	  height	  but	   also	   in	  weight.	  The	  detected	   increase	   in	  weight	   is	  
based	  on	  an	  increase	  in	  FFM	  and	  not	  in	  FM.	  This	  means,	  as	  mentioned	  before,	  that	  
the	  body	  composition	  in	  SGA	  children	  improves	  after	  receiving	  rhGH	  treatment.	  In	  
SGA	  children	  rhGH	  treatment	  prevents	  overweight	  and	  thereby	  the	  metabolic	  syn-­‐
drome.	  
	  
To	  evaluate	  adequate	  and	  inadequate	  responders	  to	  rhGH	  therapy,	  with	  respect	  to	  
height,	  changes	  in	  body	  composition	  can	  be	  measured.	  The	  change	  in	  body	  compo-­‐
sition	  is	  an	  actual	  tool	  in	  predicting	  the	  individual	  response	  on	  rhGH	  treatment.	  By	  
using	  this	  method	  rhGH	  therapy	  can	  be	  given	  only	  to	  adequate	  responders	  and	  it	  is	  
possible	  to	  prevent	  aimless	  administration.	  	  
	  
In	  obese	  children	  there	  exists	  a	  decrease	  in	  growth	  hormone	  (GH)	  secretion	  what	  is	  
fully	  reversible	  when	  body	  weight	   is	  normalized13.	  A	  decrease	   in	  spontaneous	  GH	  
release	   in	   obesity	   has	   been	   confirmed	   in	   several	   comparative	   studies	   on	   the	   24-­‐
hour	  secretion	  of	  GH	  in	  normal	  weight14	  and	  obese	  children13,	  15.	  In	  obese	  children,	  
GH	   secretion	  may	   be	   as	   low	   as	   in	   poorly	   growing	   children	   with	   classical	   GHD16.	  
Investigation	   of	   the	   pattern	   of	   factors	   potentially	   influencing	   GH	   secretion	   con-­‐
firmed	  a	  significant	  and	  independent	  impact	  of	  fat	  mass.	  Relative	  adiposity	  acts	  as	  a	  
negative	  determinant	  of	  the	  frequency	  and	  amplitude	  of	  GH	  secretory	  bursts.	  They	  
are	  associated	  with	  an	  increased	  GH	  clearance	  leading	  to	  a	  lower	  GH	  half-­‐life	  time,	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suggesting	  a	  defect	  both	  in	  secretion	  and	  clearance15,	  17.	  Alterations	  in	  GH	  receptors	  
and	  circulating	  GH-­‐binding	  proteins	  support	  these	  changes18,	  19.	  	  
	  
Bocca	   et	   al	   showed	   that	   insulin	   resistance	   and	   cardiovascular	   risk	   factors	   are	   al-­‐
ready	  evident	   in	  overweight	  and	  obese	  children	  with	  a	  mean	  age	  of	  4.7	  years.	  An	  
association	   exists	   between	   insulin	   resistance	   and	   BMI,	   waist	   circumference	   and	  
percentage	   body	   fat20.	   The	   question	   arises	   if	   obesity	  will	   improve	   by	   rhGH	   treat-­‐
ment.	   It	   is	   dubious	   to	   give	   rhGH	   treatment	   to	   obese	   children.	  However,	   if	   a	   child	  
suffers	  from	  obesity	  due	  to	  an	  insulin	  resistance,	  rhGH	  therapy	  is	  theoretically	  indi-­‐
cated	  but,	  as	  in	  all	  cases	  of	  insulin	  resistance	  known	  as	  diabetic	  type	  II,	  the	  first	  step	  
is	  lowering	  weight	  by	  means	  of	  dietary	  measures.	  	  
	  
One	  can	  discuss	  if	  rhGH	  treatment	  is	  indicated	  in	  very	  obese	  children.	  Like	  bariatric	  
surgery,	   these	   treatment	   options	   are	   controversial	   in	   pediatric	   patients.	   Bariatric	  
surgery	  in	  children	  results	  in	  clinically	  significant	  weight	  loss,	  but	  also	  has	  the	  po-­‐
tential	   for	  serious	  complications21.	  Therefore,	   this	   is	  not	  a	  usual	   treatment	  option.	  
But	   in	  the	  case	  of	  severe	  obesity,	  where	  other	  treatment	  options	   failed,	   it	   is	  ques-­‐
tionable	   if	  more	   risky	   therapies,	   under	   strict	  monitoring,	   are	   indicated	   if	  we	   take	  
the	  severe	  comorbidities	  of	  obesity	  into	  account.	  
Costs	  
Not	  only	  the	  health	  consequences	  of	  overweight	  in	  childhood	  are	  a	  serious	  problem,	  
but	  also	  the	  financial	  aspect.	  Consequences	  and	  comorbidities	  of	  obesity	  like	  cardi-­‐
ovascular	   diseases,	  DM	   type	   II,	   orthopedic	   problems,	   skin	   abnormalities	   and	  psy-­‐
chosocial	  problems	  such	  as	  underachievement	  in	  school	  and	  lower	  self-­‐esteem,	  will	  
lead	  to	  rising	  health	  care	  costs	  if	  the	  incidence	  of	  obesity	  is	  increasing	  in	  the	  future.	  
Treating	  obesity	  and	  obesity-­‐related	  conditions	  costs	  billions	  of	  dollars	  a	  year.	  By	  
one	   estimate,	   the	   United	   States	   spent	   $190	   billion	   on	   obesity-­‐related	   health	   care	  
expenses	  in	  2005,	  double	  previous	  estimates22.	  The	  medical	  costs	  of	  obesity-­‐related	  
illnesses	   in	   the	   United	   States	   have	   been	   estimated	   at	   $209.7	   billion	   annually	   (in	  
2008)23.	  
	  
Not	   only	   these	   direct	   costs	   have	   to	   be	   taken	   into	   consideration,	   but	   also	   indirect	  
costs	  like	  absence	  from	  work	  due	  to	  ilness.	  Obese	  employees	  miss	  more	  days	  from	  
work	  due	   to	   short-­‐term	  absences,	   long-­‐term	  disability,	   and	  premature	  death	   than	  
non-­‐obese	  employees24.	  Some	  studies	  show	  that	  obese	  employees	  have	  also	  lower	  
wages25.	  One	  can	  imagine	  that	  obese	  persons	  with	  possible	  psychosocial	  problems	  
and	   lower	   self-­‐esteem	   due	   to	   their	  weight	   are	   less	   likely	   to	   ask	   for	   increment	   in	  
salary	  or	  improvement	  of	  career	  options.	  One	  can	  imagine	  that	  these	  problems	  also	  
apply	   for	   children	   at	   school.	   Obese	   children	   suffer	   from	   bullying,	   are	   less	   self-­‐
assured	  and	  therefore	  probably	  less	  motivated	  to	  go	  to	  school.	  
